Evidence map›Paper›PMID 29059216›Full record

ArticlePloS one2017

Protective effect of dexamethasone on 5-FU-induced oral mucositis in hamsters.

Susana Barbosa Ribeiro, Aurigena Antunes de Araújo, Raimundo Fernandes de Araújo Júnior, Gerly Anne de Castro Brito, Renata Carvalho Leitão, Maisie Mitchele Barbosa, Vinicius Barreto Garcia, Aldo Cunha Medeiros, Caroline Addison Carvalho Xavier de Medeiros

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment-induced severe oral mucositis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2019
    Article
  18. Anthocyanins Extracted fromInternational journal of molecular sciences · 2018
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Susana Barbosa RibeiroPost Graduation Program in Biotechnology RENORBIO, UFRN, Natal, RN, Brazil.
Aurigena Antunes de AraújoPost Graduation Program Public Health/Post Graduation Program in Pharmaceutical Science/Department of Biophysics and Pharmacology, UFRN, Natal, RN, Brazil.
Raimundo Fernandes de Araújo JúniorPost Graduation Program in Functional and Structural Biology/Post Graduation Program Health Science/Department of Morphology, UFRN, Natal, RN, Brazil.
Gerly Anne de Castro BritoPost Graduation Program of Morphological Science/Department of Morphology, UFC, Fortaleza, CE, Brazil.
Renata Carvalho LeitãoPost Graduation Program of Morphological Science/Department of Morphology, UFC, Fortaleza, CE, Brazil.
Maisie Mitchele BarbosaPost Graduation Program in Biological Sciences, UFRN, Natal, RN, Brazil.
Vinicius Barreto GarciaPost Graduation Program Health Science, UFRN, Natal, RN, Brazil.
Aldo Cunha MedeirosPost Graduation Program Health Science, Department of Surgery, UFRN, Natal, RN, Brazil.
Caroline Addison Carvalho Xavier de MedeirosPost Graduation Program in Biotechnology RENORBIO/ Post Graduation Program in Biological Sciences/ Department of Biophysics and Pharmacology, UFRN, Natal, RN, Brazil.ORCID http://orcid.org/0000-0001-9224-2434
Universidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral mucositis (OM) is an important side effect of cancer treatment, characterized by ulcerative lesions in the mucosa of patients undergoing radiotherapy or chemotherapy, which has marked effects on patient quality of life and cancer therapy continuity. Considering that few protocols have demonstrated efficacy in preventing this side effect, the aim of this study was to examine the effect of dexamethasone (DEX) on OM induced by 5-fluorouracil (5-FU) in hamsters by studying signaling pathways. OM was induced in hamsters by 5-FU followed by mechanical trauma (MT) on day 4. On day 10, the animals were euthanized. The experimental groups included saline, MT, 5-FU, and DEX (0.25, 0.5, or 1 mg/kg). Macroscopic, histopathological, and immunohistochemical analyses as well as immunofluorescence experiments were performed on the oral mucosa of the animals. The oral mucosal samples were analyzed by enzyme-linked immunosorbent assays, and quantitative real-time polymerase chain reaction (qPCR). DEX (0.5 or 1 mg/kg) reduced inflammation and ulceration of the oral mucosa of hamsters. In addition, DEX (1 mg/kg) reduced the cytokine levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and macrophage migration inhibitory factor (MIF). DEX (1 mg/kg) also reduced the immunoexpression of cyclooxygenase (COX)-2, matrix metalloproteinase (MMP)-2, transforming growth factor (TGF)-β, MIF, Smad 2/3, Smad 2/3 phosphorylated and NFκB p65 in the jugal mucosa. Finally, DEX (1 mg/kg) increased interleukin-1 receptor-associated kinase 3 (IRAK-M), glucocorticoid-induced leucine zipper (GILZ), and mitogen-activated protein kinase (MKP1) gene expression and reduced NFκB p65 and serine threonine kinase (AKt) gene expression, relative to the 5-FU group. Thus, DEX improved OM induced by 5-FU in hamsters.

Indexed as

AnimalsCricetinaeCyclooxygenase 2CytokinesDexamethasoneFluorouracilMaleMatrix Metalloproteinase 2MesocricetusNF-kappa BPhosphorylationSmad ProteinsStomatitisTransforming Growth Factor betaCyclooxygenase 2CytokinesDexamethasoneFluorouracilMatrix Metalloproteinase 2NF-kappa BSmad ProteinsTransforming Growth Factor beta

Identifiers

PMID29059216
PMCPMC5653368
OpenAlexW2765678735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.